The Impacts of Inclusion in Clinical Trials on Outcomes among Patients with Metastatic Breast Cancer (MBC)

BACKGROUND: Metastatic breast cancer (MBC) remains a devastating and incurable disease. Over the past decade, the implementation of clinical trials both with and without molecular targeted therapeutics has impacted the daily clinical treatment of patients with MBC. In this study, we determine whethe...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Ji Yun, Lim, Sung Hee, Lee, Min-Young, Kim, Hae Su, Ahn, Jin Seok, Im, Young-Hyuck, Park, Yeon Hee
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4763476/
https://www.ncbi.nlm.nih.gov/pubmed/26901062
http://dx.doi.org/10.1371/journal.pone.0149432

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4763476/
https://www.ncbi.nlm.nih.gov/pubmed/26901062
http://dx.doi.org/10.1371/journal.pone.0149432

Ejemplares similares